Related Experiment Video
Updated: Apr 25, 2026

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
Structural and biochemical basis of ROC-dependent activation of LRRK2
Yangshin Park1,2, Chunxiang Wu1,2, Kayla Tennessen1,2
1Department of Biochemistry, Molecular Biology, and Pharmacology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Mutations in leucine-rich repeat kinase 2 (LRRK2) drive Parkinson's disease. This study reveals how the ROC domain's conformational changes intrinsically regulate LRRK2 activation, offering new insights into disease mechanisms.
Area of Science:
- Biochemistry
- Structural Biology
- Neuroscience
Background:
- Mutations in leucine-rich repeat kinase 2 (LRRK2) are a leading genetic cause of Parkinson's disease.
- The precise molecular mechanisms controlling LRRK2 activation are not fully understood.
Purpose of the Study:
- To elucidate the role of the Ras of complex proteins (ROC) GTPase domain in LRRK2 activation.
- To define the conformational dynamics governing LRRK2 kinase activity.
Main Methods:
- Cryo-electron microscopy (Cryo-EM) of full-length LRRK2.
- X-ray crystallography of the LRRK2 ROC domain.
- Structure-guided biochemical perturbations and disulfide engineering.
Main Results:
- LRRK2 exists in three intrinsic conformational states: autoinhibited, intermediate, and activated.
- The ROC domain exhibits inherent conformational plasticity influencing LRRK2 activation.
- A functional coupling between R1441 and switch II directly impacts GTPase activity, mimicking disease mutations.
Conclusions:
- The ROC domain acts as a dynamic regulator of LRRK2 activation through intramolecular conformational changes.
- Pathogenic LRRK2 mutations may promote aberrant kinase activity by disrupting this intrinsic activation pathway.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Receptor Tyrosine Kinases
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
MAPK Signaling Cascades
Parkinson Disease ll: Pathophysiology
Lysosomal Hydrolases

